142 related articles for article (PubMed ID: 32436860)
1. GAD-65 autoantibody associated epilepsy.
Dimova R; Grozeva G; Chakarova N; Tsarkova P; Tankova T
J Pediatr Endocrinol Metab; 2020 May; 33(6):817-820. PubMed ID: 32436860
[TBL] [Abstract][Full Text] [Related]
2. Anti glutamate-decarboxylase antibodies: a liaison between localisation related epilepsy, stiff-person syndrome and type-1 diabetes mellitus.
Szűcs A; Barcs G; Winkler G; Soós Z; Folyovich A; Kelemen A; Várallyay P; Kamondi A
Ideggyogy Sz; 2014 Jul; 67(7-8):269-71. PubMed ID: 25509368
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycemic seizures and epilepsy in type I diabetes mellitus.
Falip M; Miró J; Carreño M; Jaraba S; Becerra JL; Cayuela N; Perez Maraver M; Graus F
J Neurol Sci; 2014 Nov; 346(1-2):307-9. PubMed ID: 25183236
[TBL] [Abstract][Full Text] [Related]
4. Glutamic acid decarboxylase autoantibody-positivity post-partum is associated with impaired β-cell function in women with gestational diabetes mellitus.
Lundberg TP; Højlund K; Snogdal LS; Jensen DM
Diabet Med; 2015 Feb; 32(2):198-205. PubMed ID: 25345799
[TBL] [Abstract][Full Text] [Related]
5. Electroencephalographic abnormalities in children with type 1 diabetes mellitus: a prospective study.
Yildirim R; Günbey C
Turk J Med Sci; 2023; 53(6):1794-1798. PubMed ID: 38813513
[TBL] [Abstract][Full Text] [Related]
6. Type 1 diabetes mellitus and drug-resistant epilepsy: presence of high titer of anti-glutamic acid decarboxylase autoantibodies in serum and cerebrospinal fluid.
Yoshimoto T; Doi M; Fukai N; Izumiyama H; Wago T; Minami I; Uchimura I; Hirata Y
Intern Med; 2005 Nov; 44(11):1174-7. PubMed ID: 16357456
[TBL] [Abstract][Full Text] [Related]
7. Seizures and type 1 diabetes mellitus: current state of knowledge.
Verrotti A; Scaparrotta A; Olivieri C; Chiarelli F
Eur J Endocrinol; 2012 Dec; 167(6):749-58. PubMed ID: 22956556
[TBL] [Abstract][Full Text] [Related]
8. Glutamic acid decarboxylase (GAD) antibodies in epilepsy: diagnostic yield and therapeutic implications.
Lilleker JB; Biswas V; Mohanraj R
Seizure; 2014 Sep; 23(8):598-602. PubMed ID: 24836709
[TBL] [Abstract][Full Text] [Related]
9. Musicogenic reflex seizures in epilepsy with glutamic acid decarbocylase antibodies.
Falip M; Rodriguez-Bel L; Castañer S; Miro J; Jaraba S; Mora J; Bas J; Carreño M
Acta Neurol Scand; 2018 Feb; 137(2):272-276. PubMed ID: 28766694
[TBL] [Abstract][Full Text] [Related]
10. GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies.
Liimatainen S; Honnorat J; Pittock SJ; McKeon A; Manto M; Radtke JR; ; Hampe CS
Orphanet J Rare Dis; 2018 Apr; 13(1):55. PubMed ID: 29636076
[TBL] [Abstract][Full Text] [Related]
11. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
[TBL] [Abstract][Full Text] [Related]
12. Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy.
Daif A; Lukas RV; Issa NP; Javed A; VanHaerents S; Reder AT; Tao JX; Warnke P; Rose S; Towle VL; Wu S
Epilepsy Behav; 2018 Mar; 80():331-336. PubMed ID: 29433947
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy.
Peltola J; Kulmala P; Isojärvi J; Saiz A; Latvala K; Palmio J; Savola K; Knip M; Keränen T; Graus F
Neurology; 2000 Jul; 55(1):46-50. PubMed ID: 10891904
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to glutamic acid decarboxylase (GAD), 64,000-Mr islet cell protein (64K) antibodies and islet cell antibodies (ICA) in insulin-dependent diabetes mellitus with and without autoimmune diseases in Japan.
Akawaza S; Kawasaki E; Yano M; Abiru N; Yamaguchi Y; Nagataki S
Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S89-93. PubMed ID: 7859640
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
[TBL] [Abstract][Full Text] [Related]
16. Non-convulsive status epilepticus associated with glutamic acid decarboxylase antibody.
Cikrikçili U; Ulusoy C; Turan S; Yildiz S; Bilgiç B; Hanagasi H; Baykan B; Tüzün E; Gürvit H
Clin EEG Neurosci; 2013 Jul; 44(3):232-6. PubMed ID: 23820312
[TBL] [Abstract][Full Text] [Related]
17. Epilepsy and behavioral changes, type 1 diabetes mellitus and a high titer of glutamic acid decarboxylase antibodies.
Ganelin-Cohen E; Modan-Moses D; Hemi R; Kanety H; Ben-Zeev B; Hampe CS
Pediatr Diabetes; 2016 Dec; 17(8):617-622. PubMed ID: 26711844
[TBL] [Abstract][Full Text] [Related]
18. Refractory status epilepticus and glutamic acid decarboxylase antibodies in adults: presentation, treatment and outcomes.
Khawaja AM; Vines BL; Miller DW; Szaflarski JP; Amara AW
Epileptic Disord; 2016 Mar; 18(1):34-43. PubMed ID: 26878120
[TBL] [Abstract][Full Text] [Related]
19. A monoclonal antibody-based characterization of autoantibodies against glutamic acid decarboxylase in adults with latent autoimmune diabetes.
Ziegler B; Strebelow M; Rjasanowski I; Schlosser M; Ziegler M
Autoimmunity; 1998; 28(2):61-8. PubMed ID: 9771977
[TBL] [Abstract][Full Text] [Related]
20. GAD65 antibody-associated autoimmune epilepsy with unique independent bitemporal-onset ictal asystole.
D'Souza CE; Feyissa AM
Epileptic Disord; 2018 Jun; 20(3):204-208. PubMed ID: 29905150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
